Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: Systematic review and meta-analysis

Lancet Neurology

Volumn 4, Issue 6, 2005, Pages 371-380

  Kuo, Hsu Ko ^a,b   Yen, Chung Jen ^b,e   Chang, Chia Hsuin ^b   Kuo, Chen Ko ^c   Chen, Jen Hau ^d   Sorond, Farzaneh ^d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

CLINICAL TRIAL; COGNITIVE DEFECT; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); DEMENTIA; DEPRESSION; FOLLOW UP; HOSPITAL; HUMAN; MEDICAL RESEARCH; MEDLINE; META ANALYSIS; OUTCOMES RESEARCH; POPULATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; STROKE; SYSTEMATIC REVIEW;

EID: 19344365429     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70099-5     Document Type: Note

References (84)

1. PM Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
2. C Gabay, I Kushner Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 1999 448 454
3. A Paul, KW Ko, L Li C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice Circulation 109 2004 647 655
4. PM Ridker, N Rifai, M Clearfield Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344 2001 1959 1965
5. PM Ridker, CH Hennekens, JE Buring, N Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
6. PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
7. W Koenig, M Sund, M Frohlich C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation 99 1999 237 242
8. RP Tracy, RN Lemaitre, BM Psaty Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler Thromb Vasc Biol 17 1997 1121 1127
9. AD Pradhan, JE Manson, JE Rossouw Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study JAMA 288 2002 980 987
10. J Danesh, P Whincup, M Walker Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses BMJ 321 2000 199 204
11. CM Albert, J Ma, N Rifai, MJ Stampfer, PM Ridker Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death Circulation 105 2002 2595 2599
12. LH Kuller, RP Tracy, J Shaten, EN Meilahn Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial Am J Epidemiol 144 1996 537 547
13. MA Mendall, DP Strachan, BK Butland C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men Eur Heart J 21 2000 1584 1590
14. D Pratico, JQ Trojanowski Inflammatory hypotheses: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol Aging 21 2000 441 445
15. M Hull, S Strauss, M Berger, B Volk, J Bauer Inflammatory mechanisms in Alzheimer's disease Eur Arch Psychiatry Clin Neurosci 246 1996 124 128
16. M Maes, E Vandoolaeghe, R Ranjan, E Bosmans, R Bergmans, R Desnyder Increased serum interleukin-1-receptor-antagonist concentrations in major depression J Affect Disord 36 1995 29 36
17. M Maes, HY Meltzer, E Bosmans Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression J Affect Disord 34 1995 301 309
18. T Duong, M Nikolaeva, PJ Acton C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease Brain Res 749 1997 152 156
19. N Iwamoto, E Nishiyama, J Ohwada, H Arai Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections Neurosci Lett 177 1994 23 26
20. M Berk, AA Wadee, RH Kuschke, A O'Neill-Kerr Acute phase proteins in major depression J Psychosom Res 43 1997 529 534
21. GE Miller, CA Stetler, RM Carney, KE Freedland, WA Banks Clinical depression and inflammatory risk markers for coronary heart disease Am J Cardiol 90 2002 1279 1283
22. M Maes, S Scharpe, E Bosmans Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness Prog Neuropsychopharmacol Biol Psychiatry 16 1992 501 515
23. JJ Deeks, DG Altman, MJ Bradburn Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis M Egger G Davey Smith DG Altman Systematic reviews in health care: meta-analysis in context 2nd edn. 2001 BMJ Publishing Group London 285 312
24. ES Ford, WH Giles Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey Arterioscler Thromb Vasc Biol 20 2000 1052 1056
25. E van Exel, J Gussekloo, AJ de Craen, A Bootsma-van der Wiel, M Frolich, RG Westendorp Inflammation and stroke: the Leiden 85-Plus Study Stroke 33 2002 1135 1138
26. NS Rost, PA Wolf, CS Kase Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study Stroke 32 2001 2575 2579
27. JD Curb, RD Abbott, BL Rodriguez C-reactive protein and the future risk of thromboembolic stroke in healthy men Circulation 107 2003 2016 2020
28. JJ Cao, C Thach, TA Manolio C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study Circulation 108 2003 166 170
29. M Cesari, BW Penninx, AB Newman Inflammatory markers and onset of cardiovascular events: results from the Health ABC Study Circulation 108 2003 2317 2322
30. G Ravaglia, P Forti, F Maioli The clock-drawing test in elderly Italian community dwellers: associations with sociodemographic status and risk factors for vascular cognitive impairment Dement Geriatr Cogn Disord 16 2003 287 295
31. CE Teunissen, MP van Boxtel, H Bosma Inflammation markers in relation to cognition in a healthy aging population J Neuroimmunol 134 2003 142 150
32. RS Tilvis, MH Kahonen-Vare, J Jolkkonen, J Valvanne, KH Pitkala, TE Strandberg Predictors of cognitive decline and mortality of aged people over a 10-year period J Gerontol A Biol Sci Med Sci 59 2004 268 274
33. K Yaffe, K Lindquist, BW Penninx Inflammatory markers and cognition in well-functioning African-American and white elders Neurology 61 2003 76 80
34. MJ Engelhart, MI Geerlings, J Meijer Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study Arch Neurol 61 2004 668 672
35. R Schmidt, H Schmidt, JD Curb, K Masaki, LR White, LJ Launer Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study Ann Neurol 52 2002 168 174
36. M Danner, SV Kasl, JL Abramson, V Vaccarino Association between depression and elevated C-reactive protein Psychosom Med 65 2003 347 356
37. DE Ford, TP Erlinger Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey Arch Intern Med 164 2004 1010 1014
38. WJ Kop, JS Gottdiener, CM Tangen Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia Am J Cardiol 89 2002 419 424
39. BW Penninx, SB Kritchevsky, K Yaffe Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study Biol Psychiatry 54 2003 566 572
40. DB Panagiotakos, C Pitsavos, C Chrysohoou Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people: the ATTICA study Eur Heart J 25 2004 492 499
41. H Tiemeier, A Hofman, HR van Tuijl, AJ Kiliaan, J Meijer, MM Breteler Inflammatory proteins and depression in the elderly Epidemiology 14 2003 103 107
42. R Ross Atherosclerosis: an inflammatory disease N Engl J Med 340 1999 115 126
43. J Torzewski, M Torzewski, DE Bowyer C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries Arterioscler Thromb Vasc Biol 18 1998 1386 1392
44. M Torzewski, C Rist, RF Mortensen C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis Arterioscler Thromb Vasc Biol 20 2000 2094 2099
45. J Cermak, NS Key, RR Bach, J Balla, HS Jacob, GM Vercellotti C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor Blood 82 1993 513 520
46. P Ebeling Monocyte tissue factor induction by C-reactive protein and relationship with hormone replacement treatment Circulation 103 2001 E49
47. TP Zwaka, V Hombach, J Torzewski C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis Circulation 103 2001 1194 1197
48. R Ross Atherosclerosis is an inflammatory disease Am Heart J 138 1999 S419 S420
49. Y Hattori, M Matsumura, K Kasai Vascular smooth muscle cell activation by C-reactive protein Cardiovasc Res 58 2003 186 195
50. CH Wang, SH Li, RD Weisel C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle Circulation 107 2003 1783 1790
51. S Verma, TJ Anderson The ten most commonly asked questions about endothelial function in cardiology Cardiol Rev 9 2001 250 252
52. S Verma, CH Wang, SH Li A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 106 2002 913 919
53. SK Venugopal, S Devaraj, I Yuhanna, P Shaul, I Jialal Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 2002 1439 1441
54. S Fichtlscherer, M Kaszkin, S Breuer, S Dimmeler, AM Zeiher Elevated secretory non-pancreatic type II phospholipase A2 serum activity is associated with impaired endothelial vasodilator function in patients with coronary artery disease Clin Sci (Lond) 106 2004 511 517
55. SJ Cleland, N Sattar, JR Petrie, NG Forouhi, HL Elliott, JM Connell Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease Clin Sci (Lond) 98 2000 531 535
56. V Pasceri, JT Willerson, ET Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
57. V Pasceri, JS Cheng, JT Willerson, ET Yeh, J Chang Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 103 2001 2531 2534
58. T Duong, PJ Acton, RA Johnson The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions Brain Res 813 1998 303 312
59. PL McGeer, EG McGeer, K Yasojima Alzheimer disease and neuroinflammation J Neural Transm Suppl 59 2000 53 57
60. HK Kuo, LA Lipsitz Cerebral white matter changes and geriatric syndromes: is there a link? J Gerontol A Biol Sci Med Sci 59 2004 818 826
61. S Stephens, RA Kenny, E Rowan Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke Int J Geriatr Psychiatry 19 2004 1053 1057
62. BT Mast Cerebrovascular disease and late-life depression: a latent-variable analysis of depressive symptoms after stroke Am J Geriatr Psychiatry 12 2004 315 322
63. PM Ridker, N Rifai, L Rose, JE Buring, NR Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
64. GJ Blake, PM Ridker, KM Kuntz Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels J Am Coll Cardiol 40 2002 49 55
65. ET Yeh, JT Willerson Coming of age of C-reactive protein: using inflammation markers in cardiology Circulation 107 2003 370 371
66. NB Beamer, BM Coull, WM Clark, DP Briley, M Wynn, G Sexton Persistent inflammatory response in stroke survivors Neurology 50 1998 1722 1728
67. K Fassbender, S Rossol, T Kammer Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease J Neurol Sci 122 1994 135 139
68. M Di Napoli, F Papa, V Bocola Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke Stroke 32 2001 133 138
69. M Di Napoli, F Papa Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients Stroke 33 2002 1763 1771
70. TA Pearson, GA Mensah, RW Alexander Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
71. ES Ford Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults Epidemiology 13 2002 561 568
72. SG Wannamethee, GD Lowe, PH Whincup, A Rumley, M Walker, L Lennon Physical activity and hemostatic and inflammatory variables in elderly men Circulation 105 2002 1785 1790
73. DF Geffken, M Cushman, GL Burke, JF Polak, PA Sakkinen, RP Tracy Association between physical activity and markers of inflammation in a healthy elderly population Am J Epidemiol 153 2001 242 250
74. MA Albert, RJ Glynn, PM Ridker Effect of physical activity on serum C-reactive protein Am J Cardiol 93 2004 221 225
75. RM Robertson, L Smaha Can a Mediterranean-style diet reduce heart disease? Circulation 103 2001 1821 1822
76. C Chrysohoou, DB Panagiotakos, C Pitsavos, UN Das, C Stefanadis Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA Study J Am Coll Cardiol 44 2004 152 158
77. K Esposito, R Marfella, M Ciotola Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial JAMA 292 2004 1440 1446
78. PM Ridker, N Rifai, MA Pfeffer, F Sacks, E Braunwald Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators Circulation 100 1999 230 235
79. PM Ridker Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial Circulation 108 2003 2292 2297
80. JS Pankow, AR Folsom, M Cushman Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study Atherosclerosis 154 2001 681 689
81. DJ Brull, N Serrano, F Zito Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease Arterioscler Thromb Vasc Biol 23 2003 2063 2069
82. PJ Lindsberg, AJ Grau Inflammation and infections as risk factors for ischemic stroke Stroke 34 2003 2518 2532
83. K Wada-Isoe, Y Wakutani, K Urakami, K Nakashima Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients Acta Neurol Scand 110 2004 124 127
84. J Licinio, ML Wong The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection Mol Psychiatry 4 1999 317 327